• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEODENT - JJGC S.A. CM DRIVE IMPLANT, TITANIUM, 3.5X18 MM; ENDOSSEOUS DENTAL IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEODENT - JJGC S.A. CM DRIVE IMPLANT, TITANIUM, 3.5X18 MM; ENDOSSEOUS DENTAL IMPLANT Back to Search Results
Catalog Number 109.1006
Medical Device Problem Code Failure to Osseointegrate (1863)
Health Effect - Clinical Code Tissue Damage (2104)
Date of Event 06/11/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Exemption number: e2015015.Instradent usa, inc is submitting the report on behalf of neodent - jjgc.
 
Event or Problem Description
The clinician reported that nearly 4 months after the dental implant and abutment were placed in ada site 16 the mouth, the implant had not yet achieved osseointegration in type ii bone.The product will be forwarded to the manufacturer for investigation.There were no reported complications.
 
Additional Manufacturer Narrative
Exemption number: e2015015.Instradent usa, inc is submitting the report on behalf of neodent - jjgc.
 
Event or Problem Description
The clinician reported that nearly 4 months after the dental implant and abutment were placed in ada site 16 the mouth, the implant had not yet achieved osseointegration in type ii bone.The product will be forwarded to the manufacturer for investigation.There were no reported complications.
 
Additional Manufacturer Narrative
Exemption number: e2015015.(b)(4).Considering the surgical methodology, it was seen that the dentist has selected an implant design which is not recommended for the patient's bone quality.
 
Event or Problem Description
The clinician reported that nearly 4 months after the dental implant and abutment were placed in ada site 16 the mouth, the implant had not yet achieved osseointegration in type ii bone.The product will be forwarded to the manufacturer for investigation.There were no reported complications.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CM DRIVE IMPLANT, TITANIUM, 3.5X18 MM
Common Device Name
ENDOSSEOUS DENTAL IMPLANT
Manufacturer (Section D)
NEODENT - JJGC S.A.
av. juscelino kubitschek de
oliveira, 3291 cic
curitiba PR 81270 -200
BR  81270-200
MDR Report Key7658897
Report Number3008261720-2018-02956
Device Sequence Number134846
Product Code DZE
UDI-Device Identifier07899878023463
UDI-Public07899878023463
Combination Product (Y/N)N
Initial Reporter StateKS
Initial Reporter CountryUS
PMA/510(K) Number
K150182
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2018
Reporter Type Manufacturer
Report Source distributor,foreign
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 10/31/2018
Report Date (Section F) 06/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date12/05/2021
Device Catalogue Number109.1006
Device Lot Number86889I
Other Device ID Number07899878023463
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/11/2018
Was the Report Sent to FDA? No
Distributor Facility Aware Date11/05/2018
Device Age1 MO
Event Location Other
Date Report to Manufacturer06/18/2018
Initial Date Received by Manufacturer 06/18/2018
Supplement Date Received by Manufacturer06/18/2018
10/11/2018
Initial Report FDA Received Date07/03/2018
Supplement Report FDA Received Date10/31/2018
11/05/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age33 YR
-
-